Patents Assigned to Foundation
  • Patent number: 8164593
    Abstract: A method of rendering a graphical scene includes determining a plurality of functions that contribute to a light transport model of the scene, projecting each function of the plurality of functions into the wavelet domain, encoding basis coefficients of each function in a wavelet tree, each function being encoded in at least one wavelet tree such that the plurality of functions are represented in the wavelet domain by a plurality of wavelet trees, traversing direct paths through the plurality of wavelet trees, along which direct paths an integral coefficient may be nonzero, to determine the radiance of a point in the scene, and rendering the scene.
    Type: Grant
    Filed: March 1, 2007
    Date of Patent: April 24, 2012
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Weifeng Sun, Amar Mukherjee
  • Patent number: 8163545
    Abstract: The present disclosure provides compositions and methods for eliciting an immune response against avian or pandemic influenza. The compositions include adenovirus vectors comprising avian influenza antigens, recombinant adenovirus and immunogenic compositions comprising such recombinant vectors and adenovirus. Methods for eliciting an immune response against avian or pandemic influenza involving administering such adenovirus vectors or recombinant adenovirus are also provided.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: April 24, 2012
    Assignees: United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention, Purdue Research Foundation
    Inventors: Suryaprakash Sambhara, Jacqueline Katz, Mary Hoelscher, Suresh K. Mittal, Dinesh S. Bangari
  • Patent number: 8164424
    Abstract: A system of electronic tag has developed for integrated processing by utilizing RFID technology, which comprises a reader for collecting information, processor for processing success failure, unsure state of instruction, and a terminal for submitting transaction and receiving the result of transaction to identify.
    Type: Grant
    Filed: February 9, 2009
    Date of Patent: April 24, 2012
    Assignee: Pusan National University Industry-University Cooperation Foundation
    Inventors: Bong-Hee Hong, Ryuan Choi, Woo-Seok Ryu, Sung-Woo Ahn
  • Patent number: 8162936
    Abstract: Some embodiments of a medical instrument can be configured to reduce the formation of coagulum by delivering a negative charge bias to conductive surfaces that interface with blood or bodily tissue during a medical procedure. The application of the negative charge at the instrument-blood interface can reduce the fibrinogen deposition and the formation of coagulum because fibrinogen molecules in general are negatively charged at neutral pH levels. In addition, some embodiments of the instrument may be configured to irrigate the instrument-blood interface with RGD/ClfA peptides, a bicarbonate solution (or other high pH solution), or both to further repel the fibrinogen and thereby inhibit the formation of coagulum. Accordingly, some embodiments of the medical instrument can substantially reduce the risks of thromboembolism during particular medical procedures.
    Type: Grant
    Filed: February 20, 2009
    Date of Patent: April 24, 2012
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, Arshad Jahangir, Bernard B. C. Lim, Kalpathi L. Venkatachalam
  • Patent number: 8163347
    Abstract: Disclosed are metal oxide-polymer composites having a substrate comprising a metal oxide component, an aluminum oxide component, and a metallocene olefin polymerization catalyst component coupled to the substrate. The compositions can be used as thin films in an insulator device. Also disclosed is a method of preparing such compositions.
    Type: Grant
    Filed: November 19, 2007
    Date of Patent: April 24, 2012
    Assignees: Northwestern University, The Penn State Research Foundation
    Inventors: Tobin J. Marks, Michael T. Lanagan, Neng Guo, Sara A DiBenedetto
  • Patent number: 8164427
    Abstract: A method for optimization in an RFID location recognition system is developed to use in a blueprint in which an optimum location for installing an RFID reader is determined for using a blueprint so as to improve location recognition. The method includes the steps of inputting a blueprint and dividing a location recognition unit space from the blueprint; establishing a building interior space analysis model and an interior radio propagation space analysis model and deriving a building spatial significance and a radio propagation spatial significance; analyzing correlation between a building space and a radio propagation space and deriving a correlation coefficient; and defining an objective function for determining a location of a RFID reader based on the building spatial significance, the radio propagation spatial significance, and the correlation coefficient between the building space and the radio propagation space and performing optimization.
    Type: Grant
    Filed: December 24, 2008
    Date of Patent: April 24, 2012
    Assignee: Pusan National University Industry-University Cooperation Foundation
    Inventors: Sung Woo Tak, Tae Hoon Kim, Byung Hoon Kim, Ki Joune Li, Chi Won Son, Dong Geon Lee, Young Mann Kim
  • Patent number: 8163493
    Abstract: Provided herein are targets that can be used for the diagnosis, prognosis and therapy of a variety of cancers.
    Type: Grant
    Filed: December 24, 2008
    Date of Patent: April 24, 2012
    Assignee: The Cleveland Clinic Foundation
    Inventors: Charis Eng, Frank Weber
  • Publication number: 20120094347
    Abstract: The present invention provides enriched polynucleotides, and enriched polypeptides having pectinase activity. The present invention also includes methods of using the polynucleotides and polypeptides described herein. For instance, the methods include producing a metabolic product, such as ethanol.
    Type: Application
    Filed: September 18, 2009
    Publication date: April 19, 2012
    Applicant: University of Georgia Research Foundation, Inc.
    Inventor: Joy Doran Peterson
  • Publication number: 20120094189
    Abstract: Disclosed is a lithium-sulfur polymer battery having a anode and a cathode separated by an electrolyte formed by a membrane containing a solution of a lithium salt in aprotic organic solvents with the addition of lithium sulfide and/or lithium polysulfides until saturation, this solution being trapped in a polymer matrix.
    Type: Application
    Filed: April 8, 2010
    Publication date: April 19, 2012
    Applicant: IUCF-HYU (Industry-University Cooperation Foundation Hanyang Univeristy)
    Inventors: Bruno Scrosati, Jusef Hassoun
  • Publication number: 20120093796
    Abstract: The present invention relates to compositions for preventing or treating angiogenesis-mediated diseases or allergic diseases which contain, as an active ingredient, an EC-SOD protein or a vector having a polynucleotide encoding thereof. The EC-SOD protein or the vector having a polynucleotide encoding the EC-SOD protein has the effect on inhibiting angiogenesis by inhibiting the expression of VEGF and MMP-9 which induce angiogenesis. Therefore, the EC-SOD protein or the vector may be useful for preventing or treating angiogenesis-mediated diseases. And the EC-SOD protein or the vector having a polynucleotide encoding said EC-SOD protein also has the effect on inhibiting over-differentiation of Th2 cells which cause allergic diseases, inhibiting transcription factor (NF-? B), and reducing degranulation of human mast cells. Accordingly, the EC-SOD protein or the vector may be useful for preventing or treating allergy diseases.
    Type: Application
    Filed: March 24, 2008
    Publication date: April 19, 2012
    Applicant: Industry Academic Cooperation Foundation, The Catholic University of Korea
    Inventors: Dong Heon Shin, Tae Yoon Kim
  • Publication number: 20120092961
    Abstract: The various embodiments of the present invention provide a method for removing a Scholte waves and similar ground roll type waves from a seismic sea bottom data in a shallow water. The method comprises acquiring seismic sea bottom data in a shallow waters, applying a time-frequency-wave number (t-f-k) transform on the acquired seismic sea bottom data, identifying a time-frequency relationship of a surface wave based on a specific wave number, identifying a frequency-wave number relationship of a surface wave based on a specific time, designing a time varying frequency-wave number filter in the time-frequency-wave number domain to separate the surface wave, applying a time varying frequency-wave number filtering process to remove an undesired energy and inversing a filtered record by applying an inverse S-Transform operation and an inverse Fourier Transform operation.
    Type: Application
    Filed: October 12, 2011
    Publication date: April 19, 2012
    Applicants: The Petroleum Institute, Texas A&M Research Foundation, Ms. Zhao Zhang, Dr. Karl-Andreas Berteussen, Dr. Yuefeng Sun
    Inventors: Karl-Andreas Berteussen, Yuefeng Sun
  • Publication number: 20120092247
    Abstract: Computer input devices are described herein for use in manipulating digital images on a display apparatus.
    Type: Application
    Filed: March 4, 2010
    Publication date: April 19, 2012
    Applicant: Mayo Foundation for Medical Education and Research
    Inventor: Jared M. Orrock
  • Publication number: 20120095065
    Abstract: The instant invention describes macrocyclic compounds having therapeutic activity, and methods of treating disorders such as cancer, tumors and cell proliferation related disorders, or affect cell differentiation, dedifferentiation or transdifferentiation.
    Type: Application
    Filed: December 20, 2011
    Publication date: April 19, 2012
    Applicant: University of Florida Research Foundation, Inc.
    Inventors: Hendrik Luesch, Taori Kanchan, Valerie J. Paul
  • Publication number: 20120092957
    Abstract: The various embodiments herein provide a method to acquire seismic data to estimate reservoir characteristics in a shallow sea water environment. According to an embodiment herein, a method comprises acquiring four component ocean bottom cable (4C OBC) seismic data using a hydrophone and a three component geophone by varying a time delay between the shots and spacing between the shots. A full acoustic modelling process and an elastic modelling process are applied to the acquire 4C OBC seismic data to acquire a pressure data and an inline geophone data to estimate a horizontal component data and a reflected shear wave data. The estimated horizontal component data are NMO corrected and stacked by varying sampling intervals to remove noise component in the acquired seismic data. A shear wave energy data is estimated from the acquired pressure data to estimate shear wave properties of a sea bed and a subsurface carbonate reservoir.
    Type: Application
    Filed: October 12, 2011
    Publication date: April 19, 2012
    Applicants: The Petroleum Institute, Dr. Karl-Andreas Berteussen, Dr. Yuefeng Sun, Texas A&M Research Foundation
    Inventors: Karl-Andreas Berteussen, Yuefeng Sun
  • Publication number: 20120095358
    Abstract: A living body state monitor apparatus includes: a living body information acquisition device to acquire living body information containing an electrocardiography waveform and a pulse waveform from a user; an irregular heartbeat detection section to detect an irregular heartbeat from the electrocardiography waveform; and a pulse wave feature quantity extraction section to extract a pulse wave feature quantity from a pulse wave corresponding to the irregular heartbeat. Further, a living body state determination section is included to determine a danger degree on user's living body state using both of (A) information on kind and/or continued time period of an irregular heartbeat detected by the irregular heartbeat detection section, and (B) a pulse wave feature quantity extracted by the pulse wave feature quantity extraction section, and/or a variation of the extracted pulse wave feature quantity.
    Type: Application
    Filed: October 13, 2011
    Publication date: April 19, 2012
    Applicants: DENSO CORPORATION, Nippon Medical School Foundation, TOYOTA JIDOSHA KABUSHIKI KAISHA
    Inventors: Shinya MATSUNAGA, Shinji Nanba, Tsuyoshi Nakagawa, Kouki Futatsuyama, Takao Katoh, Hiroshige Murata, Hiroshi Hayashi, Motohisa Osaka, Minoru Makiguchi
  • Publication number: 20120095325
    Abstract: Disclosed herein is a method for treating a brain disease in which focused ultrasound and magnetic targeting are applied to a subject in need of such treatment, so that therapeutic agent-magnetic nanoparticle composites are directed across the blood-brain barrier to a designated locus inside the brain of the subject. Each of the composites includes a magnetic nanoparticle that is formed of an iron-based core and a shell encapsulating the iron-based core, and a therapeutic agent that is bound to the shell of the magnetic nanoparticle. The magnetic nanoparticle has a size ranging from 5 to 200 nm. The iron-based core has a crystalline structure that imparts the composites with a sufficiently high magnetization, thereby enhancing magnetic targeting of the composites to the designated locus inside the brain of the subject. The magnetic targeting treatment is conducted via a magnet providing a magnetic flux density not less than 0.18 T.
    Type: Application
    Filed: October 14, 2011
    Publication date: April 19, 2012
    Applicant: Chang Gung Medical Foundation, Linkou Branch
    Inventors: Kuo-Chen Wei, Hao-Li Liu, Mu-Yi Hua
  • Publication number: 20120095331
    Abstract: Disclosed herein is an information processing apparatus including: a lesion progress rate recognition section configured to perform prescribed image recognition processing on a plurality of entered medical images, thereby recognizing the lesion progress rate that represents the rate of progress of the disease-induced change in living body; and a presentation control section configured to cause a presentation section to present the medical images according to the lesion progress rate which has been recognized by the lesion progress rate recognition section.
    Type: Application
    Filed: September 29, 2011
    Publication date: April 19, 2012
    Applicants: Japanese Foundation for Cancer Research, Sony Corporation
    Inventor: Takeshi Ohashi
  • Publication number: 20120093933
    Abstract: The present invention is directed to co-assembled nanoparticle composition comprising denatured ?-lactoglobulin and at least one nutraceutical compound, specifically polyphenols, such as EGCG, compositions comprising same and methods of preparing thereof.
    Type: Application
    Filed: October 17, 2011
    Publication date: April 19, 2012
    Applicant: Technion Research and Development Foundation Ltd.
    Inventors: Yoav D. Livney, Avi Shpigelman
  • Patent number: 8157986
    Abstract: A magnetic nanoparticle complex includes a magnetic nanoparticle; and a ligand associated with the magnetic nanoparticle, the ligand including a functional group capable of combining with an acid component or a conjugate base of the acid component, in an oil. A method for preparing a magnetic nanopartide complex, includes preparing a pre-ligand having at least one amino group and at least one carbamate group or dithiocarbamate group; associating the pre-ligand with a magnetic nanoparticle to form a magnetic nanoparticle-ligand complex; and modifying the ligand to form a modified ligand having a functional group capable of combining with an acid component in an oil or a conjugate base of the acid component.
    Type: Grant
    Filed: August 27, 2008
    Date of Patent: April 17, 2012
    Assignee: Seoul National University Research & Development Business Foundation
    Inventor: Jin-Kyu Lee
  • Patent number: 8158117
    Abstract: The present invention provides improved methods and compositions for therapeutically controlling and/or reducing serum phosphate levels in animals and mammalian patients. The methods comprise administering to the patient an amount of a dendrimer composition effective to prevent absorption of substantial amounts of phosphate from the patient's GI tract. In a preferred version, a dose of between 2.5 and 15 grams per day is effective to prevent over 80% of phosphate present in the patient's GI tract from being absorbed. The dendrimer composition may comprise a hydrochloride, hydrobromide, hydroacetate or hydroanionic form.
    Type: Grant
    Filed: September 13, 2006
    Date of Patent: April 17, 2012
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Hector F. DeLuca, Katie Beth Williams, Katarzyna Barcyka